Developing an understanding of today’s global reimbursement paradigms can
be a daunting undertaking. Not only is it critical to understand payer coverage,
coding and payment mechanisms, but the converging nature of these variables
with global regulatory requirements can make this task overwhelmingly complex
to many medical technology companies. Moreover, manufacturers that wish to
commercialize innovative new technologies have a substantially more difficult
time communicating the value of their product(s) to reimbursement organizations.
tJûn17 Life Sciences is exceptionally experienced in this area, and has worked
with dozens of companies to successfully navigate global reimbursement system
pathways. Our company has relationships with hundreds of payers across
the globe, and can utilize these relationships to support the development and execution of successful reimbursement strategies that optimize payment levels.
Additional tJûn17 Life Sciences Advising Support
A properly developed life science product reimbursement strategy must, by necessity, include an assessment and operational alignment with its regulatory strategy. Innovation, in and of itself, is not enough for successful commercialization in any geographic area.